|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I trial to evaluate the safety and immunogenicity of rMVA-HIV(rMVA-HIV env/gag+rMVA-HIV tat/rev/nef-RT) and rFPV-HIV (rFPV-HIV env/gag+rFPV-HIV tat/rev/nef-RT) vaccines, alone or in combiniation in healthy, vaccinia-naive HIV-1 negative participants
HVTN 055 is a Phase I clinical trial to evaluate the safety and immunogenicity of rMVA-HIV and rFPV-HIV.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.